CaaS Capital Management
Overview
CaaS Capital Management is a global investment manager that provides liquidity to companies and markets, with a focus on equity capital market investments using a combined fundamental and quantitative approach.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Umoja Biopharma | Jan 2025 | Series C | Co-investor |
| HotSpot Therapeutics | Nov 2021 | Series C | - |
| Artios Pharma | Jul 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CaaS Capital Management based?
CaaS Capital Management is headquartered in New York City, New York, United States.
When was CaaS Capital Management founded?
CaaS Capital Management was founded in 2019.
How many portfolio companies does CaaS Capital Management have?
CaaS Capital Management has 3 portfolio companies in Caplight's dataset.
What are some companies in CaaS Capital Management's portfolio?
Portfolio companies visible on Caplight include Umoja Biopharma, HotSpot Therapeutics, Artios Pharma.
What was CaaS Capital Management's most recent investment shown here?
CaaS Capital Management's most recent investment in this portfolio sample was in Umoja Biopharma in 2025.
What sectors does CaaS Capital Management focus on?
CaaS Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does CaaS Capital Management focus on?
Stage focus information for CaaS Capital Management is not publicly available.
What is CaaS Capital Management's AUM?
CaaS Capital Management's assets under management are estimated between $933.6M and $971.0M.